#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Discussion
2-1	4-14	Discussion	abstract	new	ana	3-1

#Text=This is one of the first mixed methods studies to assess the “ care cascade ” and to explore the challenges associated with the implementation of ACF for TB in India .
3-1	15-19	This	abstract	giv	_	_
3-2	20-22	is	_	_	_	_
3-3	23-26	one	abstract[4]	new[4]	_	_
3-4	27-29	of	abstract[4]	new[4]	_	_
3-5	30-33	the	abstract[4]|event[6]	new[4]|new[6]	coref	12-14[74_6]
3-6	34-39	first	abstract[4]|event[6]	new[4]|new[6]	_	_
3-7	40-45	mixed	abstract[4]|event[6]	new[4]|new[6]	_	_
3-8	46-53	methods	abstract[4]|abstract|event[6]	new[4]|new|new[6]	_	_
3-9	54-61	studies	abstract[4]|event[6]	new[4]|new[6]	_	_
3-10	62-64	to	_	_	_	_
3-11	65-71	assess	_	_	_	_
3-12	72-75	the	abstract[8]	new[8]	_	_
3-13	76-77	“	abstract[8]	new[8]	_	_
3-14	78-82	care	abstract|abstract[8]	new|new[8]	coref	10-21[60_0]
3-15	83-90	cascade	abstract[8]	new[8]	_	_
3-16	91-92	”	abstract[8]	new[8]	_	_
3-17	93-96	and	_	_	_	_
3-18	97-99	to	_	_	_	_
3-19	100-107	explore	_	_	_	_
3-20	108-111	the	abstract[9]	new[9]	_	_
3-21	112-122	challenges	abstract[9]	new[9]	_	_
3-22	123-133	associated	_	_	_	_
3-23	134-138	with	_	_	_	_
3-24	139-142	the	abstract[10]	new[10]	_	_
3-25	143-157	implementation	abstract[10]	new[10]	_	_
3-26	158-160	of	abstract[10]	new[10]	_	_
3-27	161-164	ACF	abstract[10]|abstract	new[10]|new	coref	5-4
3-28	165-168	for	abstract[10]	new[10]	_	_
3-29	169-171	TB	abstract[10]|abstract[12]	new[10]|new[12]	coref	5-31[0_12]
3-30	172-174	in	abstract[10]|abstract[12]	new[10]|new[12]	_	_
3-31	175-180	India	abstract[10]|abstract[12]|place	new[10]|new[12]|new	_	_
3-32	181-182	.	_	_	_	_

#Text=Our study has a few key findings .
4-1	183-186	Our	person|abstract[15]	acc|new[15]	ana|coref|ana|coref	11-1|11-5[0_15]|11-1|11-5[0_15]
4-2	187-192	study	abstract[15]	new[15]	_	_
4-3	193-196	has	_	_	_	_
4-4	197-198	a	abstract[16]	new[16]	coref	11-4[69_16]
4-5	199-202	few	abstract[16]	new[16]	_	_
4-6	203-206	key	abstract[16]	new[16]	_	_
4-7	207-215	findings	abstract[16]	new[16]	_	_
4-8	216-217	.	_	_	_	_

#Text=First , the ACF activity had a low PTBP detection rate with only three out of 1000 apparently healthy individuals enumerated during house-to-house visits having symptoms that were suggestive of TB .
5-1	218-223	First	_	_	_	_
5-2	224-225	,	_	_	_	_
5-3	226-229	the	abstract[18]	new[18]	coref	14-2[83_18]
5-4	230-233	ACF	place|abstract[18]	giv|new[18]	coref	12-18
5-5	234-242	activity	abstract[18]	new[18]	_	_
5-6	243-246	had	_	_	_	_
5-7	247-248	a	abstract[20]	new[20]	coref	7-11[34_20]
5-8	249-252	low	abstract[20]	new[20]	_	_
5-9	253-257	PTBP	abstract[20]	new[20]	_	_
5-10	258-267	detection	abstract|abstract[20]	new|new[20]	coref	12-10[73_0]
5-11	268-272	rate	abstract[20]	new[20]	_	_
5-12	273-277	with	abstract[20]	new[20]	_	_
5-13	278-282	only	abstract[20]	new[20]	_	_
5-14	283-288	three	abstract[20]	new[20]	_	_
5-15	289-292	out	_	_	_	_
5-16	293-295	of	_	_	_	_
5-17	296-300	1000	person[21]	new[21]	coref	14-14[0_21]
5-18	301-311	apparently	person[21]	new[21]	_	_
5-19	312-319	healthy	person[21]	new[21]	_	_
5-20	320-331	individuals	person[21]	new[21]	_	_
5-21	332-342	enumerated	_	_	_	_
5-22	343-349	during	_	_	_	_
5-23	350-364	house-to-house	abstract[22]	new[22]	coref	21-8[130_22]
5-24	365-371	visits	abstract[22]	new[22]	_	_
5-25	372-378	having	_	_	_	_
5-26	379-387	symptoms	abstract	new	coref	13-8
5-27	388-392	that	_	_	_	_
5-28	393-397	were	_	_	_	_
5-29	398-408	suggestive	_	_	_	_
5-30	409-411	of	_	_	_	_
5-31	412-414	TB	abstract	giv	coref	7-27
5-32	415-416	.	_	_	_	_

#Text=Second , there was high attrition of PTBP prior to diagnosis with only two out of three PTBP who were referred actually visiting the health facility .
6-1	417-423	Second	_	_	_	_
6-2	424-425	,	_	_	_	_
6-3	426-431	there	_	_	_	_
6-4	432-435	was	_	_	_	_
6-5	436-440	high	event[25]	new[25]	coref	19-7[0_25]
6-6	441-450	attrition	event[25]	new[25]	_	_
6-7	451-453	of	event[25]	new[25]	_	_
6-8	454-458	PTBP	event[25]|abstract[26]	new[25]|new[26]	coref	12-10[0_26]
6-9	459-464	prior	event[25]|abstract[26]	new[25]|new[26]	_	_
6-10	465-467	to	event[25]	new[25]	_	_
6-11	468-477	diagnosis	event[25]|event[27]	new[25]|new[27]	coref	10-8[56_27]
6-12	478-482	with	event[25]|event[27]	new[25]|new[27]	_	_
6-13	483-487	only	event[25]|event[27]|quantity[28]	new[25]|new[27]|new[28]	_	_
6-14	488-491	two	event[25]|event[27]|quantity[28]	new[25]|new[27]|new[28]	_	_
6-15	492-495	out	event[25]	new[25]	_	_
6-16	496-498	of	event[25]	new[25]	_	_
6-17	499-504	three	event[25]|person[29]	new[25]|new[29]	coref	17-16[0_29]
6-18	505-509	PTBP	event[25]|person[29]	new[25]|new[29]	_	_
6-19	510-513	who	_	_	_	_
6-20	514-518	were	_	_	_	_
6-21	519-527	referred	_	_	_	_
6-22	528-536	actually	_	_	_	_
6-23	537-545	visiting	_	_	_	_
6-24	546-549	the	place[30]	new[30]	coref	10-33[65_30]
6-25	550-556	health	place[30]	new[30]	_	_
6-26	557-565	facility	place[30]	new[30]	_	_
6-27	566-567	.	_	_	_	_

#Text=Third , among PTBPs who undergo the diagnostic test , the sputum positivity rate was high , with one out of four having been diagnosed with TB .
7-1	568-573	Third	_	_	_	_
7-2	574-575	,	_	_	_	_
7-3	576-581	among	_	_	_	_
7-4	582-587	PTBPs	person	new	coref	9-34[52_0]
7-5	588-591	who	_	_	_	_
7-6	592-599	undergo	_	_	_	_
7-7	600-603	the	abstract[32]	new[32]	_	_
7-8	604-614	diagnostic	abstract[32]	new[32]	_	_
7-9	615-619	test	abstract[32]	new[32]	_	_
7-10	620-621	,	_	_	_	_
7-11	622-625	the	abstract[34]	giv[34]	coref	12-6[71_34]
7-12	626-632	sputum	abstract[34]	giv[34]	_	_
7-13	633-643	positivity	abstract|abstract[34]	new|giv[34]	_	_
7-14	644-648	rate	abstract[34]	giv[34]	_	_
7-15	649-652	was	_	_	_	_
7-16	653-657	high	_	_	_	_
7-17	658-659	,	_	_	_	_
7-18	660-664	with	_	_	_	_
7-19	665-668	one	quantity[35]	new[35]	_	_
7-20	669-672	out	quantity[35]	new[35]	_	_
7-21	673-675	of	quantity[35]	new[35]	_	_
7-22	676-680	four	quantity[35]|quantity	new[35]|new	_	_
7-23	681-687	having	_	_	_	_
7-24	688-692	been	_	_	_	_
7-25	693-702	diagnosed	_	_	_	_
7-26	703-707	with	_	_	_	_
7-27	708-710	TB	event	giv	coref	8-7
7-28	711-712	.	_	_	_	_

#Text=Fourth , the NNS for one TB patient was relatively high .
8-1	713-719	Fourth	_	_	_	_
8-2	720-721	,	_	_	_	_
8-3	722-725	the	abstract[38]	new[38]	coref	33-11[0_38]
8-4	726-729	NNS	abstract[38]	new[38]	_	_
8-5	730-733	for	abstract[38]	new[38]	_	_
8-6	734-737	one	abstract[38]|person[40]	new[38]|new[40]	_	_
8-7	738-740	TB	abstract[38]|abstract|person[40]	new[38]|giv|new[40]	coref	9-6
8-8	741-748	patient	abstract[38]|person[40]	new[38]|new[40]	_	_
8-9	749-752	was	_	_	_	_
8-10	753-763	relatively	_	_	_	_
8-11	764-768	high	_	_	_	_
8-12	769-770	.	_	_	_	_

#Text=Fifth , the stigma about TB , suspicion about TA , lack of support from political leaders , and low salary for TAs were the major challenges in conducting house-to-house visit for identifying the PTBPs .
9-1	771-776	Fifth	_	_	_	_
9-2	777-778	,	_	_	_	_
9-3	779-782	the	abstract[41]	new[41]	coref	17-29[0_41]
9-4	783-789	stigma	abstract[41]	new[41]	_	_
9-5	790-795	about	abstract[41]	new[41]	_	_
9-6	796-798	TB	abstract[41]|event	new[41]|giv	coref	13-13
9-7	799-800	,	abstract[41]	new[41]	_	_
9-8	801-810	suspicion	abstract[41]|abstract[43]	new[41]|new[43]	_	_
9-9	811-816	about	abstract[41]|abstract[43]	new[41]|new[43]	_	_
9-10	817-819	TA	abstract[41]|abstract[43]|person	new[41]|new[43]|new	_	_
9-11	820-821	,	abstract[41]	new[41]	_	_
9-12	822-826	lack	abstract[41]|abstract[45]	new[41]|new[45]	_	_
9-13	827-829	of	abstract[41]|abstract[45]	new[41]|new[45]	_	_
9-14	830-837	support	abstract[41]|abstract[45]|abstract[46]	new[41]|new[45]|new[46]	coref	28-9[166_46]
9-15	838-842	from	abstract[41]|abstract[45]|abstract[46]	new[41]|new[45]|new[46]	_	_
9-16	843-852	political	abstract[41]|abstract[45]|abstract[46]|person[47]	new[41]|new[45]|new[46]|new[47]	_	_
9-17	853-860	leaders	abstract[41]|abstract[45]|abstract[46]|person[47]	new[41]|new[45]|new[46]|new[47]	_	_
9-18	861-862	,	_	_	_	_
9-19	863-866	and	_	_	_	_
9-20	867-870	low	abstract[48]	new[48]	coref	9-25[50_48]
9-21	871-877	salary	abstract[48]	new[48]	_	_
9-22	878-881	for	abstract[48]	new[48]	_	_
9-23	882-885	TAs	abstract[48]|person	new[48]|new	coref	13-1[79_0]
9-24	886-890	were	_	_	_	_
9-25	891-894	the	abstract[50]	giv[50]	coref	23-1[138_50]
9-26	895-900	major	abstract[50]	giv[50]	_	_
9-27	901-911	challenges	abstract[50]	giv[50]	_	_
9-28	912-914	in	_	_	_	_
9-29	915-925	conducting	_	_	_	_
9-30	926-940	house-to-house	event[51]	new[51]	_	_
9-31	941-946	visit	event[51]	new[51]	_	_
9-32	947-950	for	_	_	_	_
9-33	951-962	identifying	_	_	_	_
9-34	963-966	the	person[52]	giv[52]	coref	10-30[0_52]
9-35	967-972	PTBPs	person[52]	giv[52]	_	_
9-36	973-974	.	_	_	_	_

#Text=Sixth , wage loss , apprehension about the diagnosis , substance abuse , and male dependency of females for seeking care at health facilities were the major challenges for PTBPs to visit the referred health facility .
10-1	975-980	Sixth	_	_	_	_
10-2	981-982	,	_	_	_	_
10-3	983-987	wage	abstract|abstract[54]	new|new[54]	coref|coref	23-4[140_54]|23-4[140_54]
10-4	988-992	loss	abstract[54]	new[54]	_	_
10-5	993-994	,	_	_	_	_
10-6	995-1007	apprehension	abstract[55]	new[55]	coref	10-26[62_55]
10-7	1008-1013	about	abstract[55]	new[55]	_	_
10-8	1014-1017	the	abstract[55]|event[56]	new[55]|giv[56]	coref	19-16[121_56]
10-9	1018-1027	diagnosis	abstract[55]|event[56]	new[55]|giv[56]	_	_
10-10	1028-1029	,	abstract[55]	new[55]	_	_
10-11	1030-1039	substance	abstract[55]|abstract[57]	new[55]|new[57]	coref	26-5[157_57]
10-12	1040-1045	abuse	abstract[55]|abstract[57]	new[55]|new[57]	_	_
10-13	1046-1047	,	abstract[55]	new[55]	_	_
10-14	1048-1051	and	abstract[55]	new[55]	_	_
10-15	1052-1056	male	abstract[55]|abstract[58]	new[55]|new[58]	_	_
10-16	1057-1067	dependency	abstract[55]|abstract[58]	new[55]|new[58]	_	_
10-17	1068-1070	of	abstract[55]|abstract[58]	new[55]|new[58]	_	_
10-18	1071-1078	females	abstract[55]|abstract[58]|person	new[55]|new[58]|new	coref	24-2
10-19	1079-1082	for	_	_	_	_
10-20	1083-1090	seeking	_	_	_	_
10-21	1091-1095	care	abstract[60]	giv[60]	_	_
10-22	1096-1098	at	abstract[60]	giv[60]	_	_
10-23	1099-1105	health	abstract[60]|place[61]	giv[60]|new[61]	coref	19-13[119_61]
10-24	1106-1116	facilities	abstract[60]|place[61]	giv[60]|new[61]	_	_
10-25	1117-1121	were	_	_	_	_
10-26	1122-1125	the	abstract[62]	giv[62]	_	_
10-27	1126-1131	major	abstract[62]	giv[62]	_	_
10-28	1132-1142	challenges	abstract[62]	giv[62]	_	_
10-29	1143-1146	for	abstract[62]	giv[62]	_	_
10-30	1147-1152	PTBPs	abstract[62]|event	giv[62]|giv	coref	16-19[98_0]
10-31	1153-1155	to	_	_	_	_
10-32	1156-1161	visit	_	_	_	_
10-33	1162-1165	the	place[65]	giv[65]	coref	21-20[133_65]
10-34	1166-1174	referred	place[65]	giv[65]	_	_
10-35	1175-1181	health	abstract|place[65]	new|giv[65]	coref	19-13
10-36	1182-1190	facility	place[65]	giv[65]	_	_
10-37	1191-1192	.	_	_	_	_

#Text=We further discuss our study findings in detail .
11-1	1193-1195	We	person	giv	ana	11-4
11-2	1196-1203	further	_	_	_	_
11-3	1204-1211	discuss	_	_	_	_
11-4	1212-1215	our	person|abstract[69]	giv|giv[69]	coref|coref	18-6[113_69]|18-6[113_69]
11-5	1216-1221	study	abstract|abstract[69]	giv|giv[69]	coref	12-3[70_0]
11-6	1222-1230	findings	abstract[69]	giv[69]	_	_
11-7	1231-1233	in	_	_	_	_
11-8	1234-1240	detail	_	_	_	_
11-9	1241-1242	.	_	_	_	_

#Text=First , the study had a low rate of PTBP detection , whereas the previous studies on ACF have consistently shown high rates of PTBP detection .
12-1	1243-1248	First	_	_	_	_
12-2	1249-1250	,	_	_	_	_
12-3	1251-1254	the	abstract[70]	giv[70]	coref	17-4[100_70]
12-4	1255-1260	study	abstract[70]	giv[70]	_	_
12-5	1261-1264	had	_	_	_	_
12-6	1265-1266	a	abstract[71]	giv[71]	_	_
12-7	1267-1270	low	abstract[71]	giv[71]	_	_
12-8	1271-1275	rate	abstract[71]	giv[71]	_	_
12-9	1276-1278	of	abstract[71]	giv[71]	_	_
12-10	1279-1283	PTBP	abstract[71]|abstract|abstract[73]	giv[71]|giv|giv[73]	coref|coref|coref|coref	12-25|12-25[78_73]|12-25|12-25[78_73]
12-11	1284-1293	detection	abstract[71]|abstract[73]	giv[71]|giv[73]	_	_
12-12	1294-1295	,	_	_	_	_
12-13	1296-1303	whereas	_	_	_	_
12-14	1304-1307	the	event[74]	giv[74]	_	_
12-15	1308-1316	previous	event[74]	giv[74]	_	_
12-16	1317-1324	studies	event[74]	giv[74]	_	_
12-17	1325-1327	on	event[74]	giv[74]	_	_
12-18	1328-1331	ACF	event[74]|abstract	giv[74]|giv	coref	14-3
12-19	1332-1336	have	_	_	_	_
12-20	1337-1349	consistently	_	_	_	_
12-21	1350-1355	shown	_	_	_	_
12-22	1356-1360	high	quantity[76]	new[76]	coref	20-9[125_76]
12-23	1361-1366	rates	quantity[76]	new[76]	_	_
12-24	1367-1369	of	quantity[76]	new[76]	_	_
12-25	1370-1374	PTBP	quantity[76]|abstract|abstract[78]	new[76]|giv|giv[78]	coref|coref|coref|coref	15-9[0_78]|15-12|15-9[0_78]|15-12
12-26	1375-1384	detection	quantity[76]|abstract[78]	new[76]|giv[78]	_	_
12-27	1385-1386	.	_	_	_	_

#Text=The TAs failed to individually enquire about symptoms that are suggestive of TB from all those who were enumerated .
13-1	1387-1390	The	person[79]	giv[79]	coref	17-33[0_79]
13-2	1391-1394	TAs	person[79]	giv[79]	_	_
13-3	1395-1401	failed	_	_	_	_
13-4	1402-1404	to	_	_	_	_
13-5	1405-1417	individually	_	_	_	_
13-6	1418-1425	enquire	_	_	_	_
13-7	1426-1431	about	_	_	_	_
13-8	1432-1440	symptoms	abstract	giv	coref	14-11[85_0]
13-9	1441-1445	that	_	_	_	_
13-10	1446-1449	are	_	_	_	_
13-11	1450-1460	suggestive	_	_	_	_
13-12	1461-1463	of	_	_	_	_
13-13	1464-1466	TB	abstract	giv	coref	16-9
13-14	1467-1471	from	_	_	_	_
13-15	1472-1475	all	_	_	_	_
13-16	1476-1481	those	_	_	_	_
13-17	1482-1485	who	_	_	_	_
13-18	1486-1490	were	_	_	_	_
13-19	1491-1501	enumerated	_	_	_	_
13-20	1502-1503	.	_	_	_	_

#Text=As the ACF activity was conducted during the daytime , the symptoms of individuals who were away from home were enquired about by speaking to adult informants .
14-1	1504-1506	As	_	_	_	_
14-2	1507-1510	the	abstract[83]	giv[83]	coref	31-6[182_83]
14-3	1511-1514	ACF	place|abstract[83]	giv|giv[83]	coref	31-6
14-4	1515-1523	activity	abstract[83]	giv[83]	_	_
14-5	1524-1527	was	_	_	_	_
14-6	1528-1537	conducted	_	_	_	_
14-7	1538-1544	during	_	_	_	_
14-8	1545-1548	the	time[84]	new[84]	_	_
14-9	1549-1556	daytime	time[84]	new[84]	_	_
14-10	1557-1558	,	_	_	_	_
14-11	1559-1562	the	abstract[85]	giv[85]	coref	15-17[94_85]
14-12	1563-1571	symptoms	abstract[85]	giv[85]	_	_
14-13	1572-1574	of	abstract[85]	giv[85]	_	_
14-14	1575-1586	individuals	abstract[85]|person	giv[85]|giv	_	_
14-15	1587-1590	who	_	_	_	_
14-16	1591-1595	were	_	_	_	_
14-17	1596-1600	away	_	_	_	_
14-18	1601-1605	from	_	_	_	_
14-19	1606-1610	home	place	new	_	_
14-20	1611-1615	were	_	_	_	_
14-21	1616-1624	enquired	_	_	_	_
14-22	1625-1630	about	_	_	_	_
14-23	1631-1633	by	_	_	_	_
14-24	1634-1642	speaking	_	_	_	_
14-25	1643-1645	to	_	_	_	_
14-26	1646-1651	adult	person[88]	new[88]	coref	16-1[95_88]
14-27	1652-1662	informants	person[88]	new[88]	_	_
14-28	1663-1664	.	_	_	_	_

#Text=Studies in the past have shown that the detection rate of PTBP may be low if the symptoms are not elicited individually .
15-1	1665-1672	Studies	abstract[89]	new[89]	coref	18-1[112_89]
15-2	1673-1675	in	abstract[89]	new[89]	_	_
15-3	1676-1679	the	abstract[89]|abstract[90]	new[89]|new[90]	_	_
15-4	1680-1684	past	abstract[89]|abstract[90]	new[89]|new[90]	_	_
15-5	1685-1689	have	_	_	_	_
15-6	1690-1695	shown	_	_	_	_
15-7	1696-1700	that	_	_	_	_
15-8	1701-1704	the	abstract[92]	new[92]	_	_
15-9	1705-1714	detection	abstract|abstract[92]	giv|new[92]	coref	17-16[104_0]
15-10	1715-1719	rate	abstract[92]	new[92]	_	_
15-11	1720-1722	of	abstract[92]	new[92]	_	_
15-12	1723-1727	PTBP	abstract[92]|event	new[92]|giv	_	_
15-13	1728-1731	may	_	_	_	_
15-14	1732-1734	be	_	_	_	_
15-15	1735-1738	low	_	_	_	_
15-16	1739-1741	if	_	_	_	_
15-17	1742-1745	the	abstract[94]	giv[94]	coref	16-8[97_94]
15-18	1746-1754	symptoms	abstract[94]	giv[94]	_	_
15-19	1755-1758	are	_	_	_	_
15-20	1759-1762	not	_	_	_	_
15-21	1763-1771	elicited	_	_	_	_
15-22	1772-1784	individually	_	_	_	_
15-23	1785-1786	.	_	_	_	_

#Text=The informants might not be aware of the TB symptoms and thus , could have failed to identify the PTBPs among those who were absent during the interview .
16-1	1787-1790	The	person[95]	giv[95]	_	_
16-2	1791-1801	informants	person[95]	giv[95]	_	_
16-3	1802-1807	might	_	_	_	_
16-4	1808-1811	not	_	_	_	_
16-5	1812-1814	be	_	_	_	_
16-6	1815-1820	aware	_	_	_	_
16-7	1821-1823	of	_	_	_	_
16-8	1824-1827	the	abstract[97]	giv[97]	coref	17-25[108_97]
16-9	1828-1830	TB	abstract|abstract[97]	giv|giv[97]	coref	17-25
16-10	1831-1839	symptoms	abstract[97]	giv[97]	_	_
16-11	1840-1843	and	_	_	_	_
16-12	1844-1848	thus	_	_	_	_
16-13	1849-1850	,	_	_	_	_
16-14	1851-1856	could	_	_	_	_
16-15	1857-1861	have	_	_	_	_
16-16	1862-1868	failed	_	_	_	_
16-17	1869-1871	to	_	_	_	_
16-18	1872-1880	identify	_	_	_	_
16-19	1881-1884	the	event[98]	giv[98]	coref	19-10[0_98]
16-20	1885-1890	PTBPs	event[98]	giv[98]	_	_
16-21	1891-1896	among	_	_	_	_
16-22	1897-1902	those	_	_	_	_
16-23	1903-1906	who	_	_	_	_
16-24	1907-1911	were	_	_	_	_
16-25	1912-1918	absent	_	_	_	_
16-26	1919-1925	during	_	_	_	_
16-27	1926-1929	the	event[99]	new[99]	_	_
16-28	1930-1939	interview	event[99]	new[99]	_	_
16-29	1940-1941	.	_	_	_	_

#Text=As explored in the qualitative study , the other potential reasons for low rate of PTBP detection are hesitancy to disclose the details of TB symptoms due to stigma and distrust about TAs .
17-1	1942-1944	As	_	_	_	_
17-2	1945-1953	explored	_	_	_	_
17-3	1954-1956	in	_	_	_	_
17-4	1957-1960	the	abstract[100]	giv[100]	_	_
17-5	1961-1972	qualitative	abstract[100]	giv[100]	_	_
17-6	1973-1978	study	abstract[100]	giv[100]	_	_
17-7	1979-1980	,	_	_	_	_
17-8	1981-1984	the	abstract[101]	new[101]	coref	17-19[0_101]
17-9	1985-1990	other	abstract[101]	new[101]	_	_
17-10	1991-2000	potential	abstract[101]	new[101]	_	_
17-11	2001-2008	reasons	abstract[101]	new[101]	_	_
17-12	2009-2012	for	abstract[101]	new[101]	_	_
17-13	2013-2016	low	abstract[101]|abstract[102]	new[101]|new[102]	_	_
17-14	2017-2021	rate	abstract[101]|abstract[102]	new[101]|new[102]	_	_
17-15	2022-2024	of	abstract[101]|abstract[102]	new[101]|new[102]	_	_
17-16	2025-2029	PTBP	abstract[101]|abstract[102]|person|event[104]	new[101]|new[102]|giv|giv[104]	_	_
17-17	2030-2039	detection	abstract[101]|abstract[102]|event[104]	new[101]|new[102]|giv[104]	_	_
17-18	2040-2043	are	_	_	_	_
17-19	2044-2053	hesitancy	abstract	giv	coref	22-8[136_0]
17-20	2054-2056	to	_	_	_	_
17-21	2057-2065	disclose	_	_	_	_
17-22	2066-2069	the	abstract[106]	new[106]	_	_
17-23	2070-2077	details	abstract[106]	new[106]	_	_
17-24	2078-2080	of	abstract[106]	new[106]	_	_
17-25	2081-2083	TB	abstract[106]|abstract|abstract[108]	new[106]|giv|giv[108]	coref|coref|coref|coref	19-16|31-19[0_108]|19-16|31-19[0_108]
17-26	2084-2092	symptoms	abstract[106]|abstract[108]	new[106]|giv[108]	_	_
17-27	2093-2096	due	_	_	_	_
17-28	2097-2099	to	_	_	_	_
17-29	2100-2106	stigma	abstract	giv	_	_
17-30	2107-2110	and	_	_	_	_
17-31	2111-2119	distrust	abstract[110]	new[110]	_	_
17-32	2120-2125	about	abstract[110]	new[110]	_	_
17-33	2126-2129	TAs	abstract[110]|abstract	new[110]|giv	coref	21-12
17-34	2130-2131	.	_	_	_	_

#Text=Some other studies also revealed similar findings .
18-1	2132-2136	Some	event[112]	giv[112]	coref	20-1[122_112]
18-2	2137-2142	other	event[112]	giv[112]	_	_
18-3	2143-2150	studies	event[112]	giv[112]	_	_
18-4	2151-2155	also	_	_	_	_
18-5	2156-2164	revealed	_	_	_	_
18-6	2165-2172	similar	abstract[113]	giv[113]	coref	20-6[123_113]
18-7	2173-2181	findings	abstract[113]	giv[113]	_	_
18-8	2182-2183	.	_	_	_	_

#Text=The second finding is the high attrition rate among PTBPs referred to health facilities for TB diagnosis .
19-1	2184-2187	The	abstract[114]	new[114]	coref	19-5[116_114]
19-2	2188-2194	second	abstract[114]	new[114]	_	_
19-3	2195-2202	finding	abstract[114]	new[114]	_	_
19-4	2203-2205	is	_	_	_	_
19-5	2206-2209	the	abstract[116]	giv[116]	coref	21-1[128_116]
19-6	2210-2214	high	abstract[116]	giv[116]	_	_
19-7	2215-2224	attrition	event|abstract[116]	giv|giv[116]	coref	20-9
19-8	2225-2229	rate	abstract[116]	giv[116]	_	_
19-9	2230-2235	among	abstract[116]	giv[116]	_	_
19-10	2236-2241	PTBPs	abstract[116]|person	giv[116]|giv	coref	21-17
19-11	2242-2250	referred	_	_	_	_
19-12	2251-2253	to	_	_	_	_
19-13	2254-2260	health	abstract|place[119]	giv|giv[119]	coref|coref|coref|coref	23-12|23-12[143_119]|23-12|23-12[143_119]
19-14	2261-2271	facilities	place[119]	giv[119]	_	_
19-15	2272-2275	for	place[119]	giv[119]	_	_
19-16	2276-2278	TB	place[119]|abstract|event[121]	giv[119]|giv|giv[121]	coref|coref|coref|coref	29-6|29-6[172_121]|29-6|29-6[172_121]
19-17	2279-2288	diagnosis	place[119]|event[121]	giv[119]|giv[121]	_	_
19-18	2289-2290	.	_	_	_	_

#Text=Previous studies have also reported similar findings with attrition rates ranging from 39 % to 80 % .
20-1	2291-2299	Previous	event[122]	giv[122]	coref	34-1[198_122]
20-2	2300-2307	studies	event[122]	giv[122]	_	_
20-3	2308-2312	have	_	_	_	_
20-4	2313-2317	also	_	_	_	_
20-5	2318-2326	reported	_	_	_	_
20-6	2327-2334	similar	abstract[123]	giv[123]	_	_
20-7	2335-2343	findings	abstract[123]	giv[123]	_	_
20-8	2344-2348	with	abstract[123]	giv[123]	_	_
20-9	2349-2358	attrition	abstract[123]|event|quantity[125]	giv[123]|giv|giv[125]	coref|coref	22-11[137_0]|22-11[137_0]
20-10	2359-2364	rates	abstract[123]|quantity[125]	giv[123]|giv[125]	_	_
20-11	2365-2372	ranging	_	_	_	_
20-12	2373-2377	from	_	_	_	_
20-13	2378-2380	39	quantity[126]	new[126]	_	_
20-14	2381-2382	%	quantity[126]	new[126]	_	_
20-15	2383-2385	to	_	_	_	_
20-16	2386-2388	80	quantity[127]	new[127]	_	_
20-17	2389-2390	%	quantity[127]	new[127]	_	_
20-18	2391-2392	.	_	_	_	_

#Text=The rate was high in spite of repeated house visits by TAs to counsel and encourage PTBPs to visit the health facility .
21-1	2393-2396	The	abstract[128]	giv[128]	coref	24-4[149_128]
21-2	2397-2401	rate	abstract[128]	giv[128]	_	_
21-3	2402-2405	was	_	_	_	_
21-4	2406-2410	high	_	_	_	_
21-5	2411-2413	in	_	_	_	_
21-6	2414-2419	spite	_	_	_	_
21-7	2420-2422	of	_	_	_	_
21-8	2423-2431	repeated	abstract[130]	giv[130]	coref	23-10[0_130]
21-9	2432-2437	house	place|abstract[130]	new|giv[130]	_	_
21-10	2438-2444	visits	abstract[130]	giv[130]	_	_
21-11	2445-2447	by	abstract[130]	giv[130]	_	_
21-12	2448-2451	TAs	abstract[130]|person	giv[130]|giv	coref	32-3[187_0]
21-13	2452-2454	to	_	_	_	_
21-14	2455-2462	counsel	_	_	_	_
21-15	2463-2466	and	_	_	_	_
21-16	2467-2476	encourage	_	_	_	_
21-17	2477-2482	PTBPs	person	giv	coref	26-1[155_0]
21-18	2483-2485	to	_	_	_	_
21-19	2486-2491	visit	_	_	_	_
21-20	2492-2495	the	place[133]	giv[133]	coref	24-19[152_133]
21-21	2496-2502	health	place[133]	giv[133]	_	_
21-22	2503-2511	facility	place[133]	giv[133]	_	_
21-23	2512-2513	.	_	_	_	_

#Text=The qualitative interviews provided good insight about potential reasons for such high attrition .
22-1	2514-2517	The	abstract[134]	new[134]	_	_
22-2	2518-2529	qualitative	abstract[134]	new[134]	_	_
22-3	2530-2540	interviews	abstract[134]	new[134]	_	_
22-4	2541-2549	provided	_	_	_	_
22-5	2550-2554	good	abstract[135]	new[135]	_	_
22-6	2555-2562	insight	abstract[135]	new[135]	_	_
22-7	2563-2568	about	abstract[135]	new[135]	_	_
22-8	2569-2578	potential	abstract[135]|abstract[136]	new[135]|giv[136]	coref	23-21[146_136]
22-9	2579-2586	reasons	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
22-10	2587-2590	for	abstract[135]|abstract[136]	new[135]|giv[136]	_	_
22-11	2591-2595	such	abstract[135]|abstract[136]|event[137]	new[135]|giv[136]|giv[137]	coref	24-5[0_137]
22-12	2596-2600	high	abstract[135]|abstract[136]|event[137]	new[135]|giv[136]|giv[137]	_	_
22-13	2601-2610	attrition	abstract[135]|abstract[136]|event[137]	new[135]|giv[136]|giv[137]	_	_
22-14	2611-2612	.	_	_	_	_

#Text=The wage or work loss due to travel and visits to health facilities during the day time was one of the major reasons .
23-1	2613-2616	The	abstract[138]	giv[138]	_	_
23-2	2617-2621	wage	abstract[138]	giv[138]	_	_
23-3	2622-2624	or	abstract[138]	giv[138]	_	_
23-4	2625-2629	work	abstract[138]|abstract|abstract[140]	giv[138]|new|giv[140]	_	_
23-5	2630-2634	loss	abstract[138]|abstract[140]	giv[138]|giv[140]	_	_
23-6	2635-2638	due	_	_	_	_
23-7	2639-2641	to	_	_	_	_
23-8	2642-2648	travel	_	_	_	_
23-9	2649-2652	and	_	_	_	_
23-10	2653-2659	visits	abstract	giv	coref	37-1[219_0]
23-11	2660-2662	to	_	_	_	_
23-12	2663-2669	health	abstract|place[143]	giv|giv[143]	coref|coref	27-13|27-13
23-13	2670-2680	facilities	place[143]	giv[143]	_	_
23-14	2681-2687	during	place[143]	giv[143]	_	_
23-15	2688-2691	the	place[143]|time[144]	giv[143]|new[144]	coref	42-27[256_144]
23-16	2692-2695	day	place[143]|time[144]	giv[143]|new[144]	_	_
23-17	2696-2700	time	place[143]|time[144]	giv[143]|new[144]	_	_
23-18	2701-2704	was	_	_	_	_
23-19	2705-2708	one	abstract[145]	new[145]	_	_
23-20	2709-2711	of	abstract[145]	new[145]	_	_
23-21	2712-2715	the	abstract[145]|abstract[146]	new[145]|giv[146]	coref	28-3[164_146]
23-22	2716-2721	major	abstract[145]|abstract[146]	new[145]|giv[146]	_	_
23-23	2722-2729	reasons	abstract[145]|abstract[146]	new[145]|giv[146]	_	_
23-24	2730-2731	.	_	_	_	_

#Text=Among females , the attrition rate was high as they were dependent on male family members to visit the health facility .
24-1	2732-2737	Among	_	_	_	_
24-2	2738-2745	females	person	giv	ana	24-10
24-3	2746-2747	,	_	_	_	_
24-4	2748-2751	the	abstract[149]	giv[149]	coref	29-3[170_149]
24-5	2752-2761	attrition	event|abstract[149]	giv|giv[149]	coref	26-11[158_0]
24-6	2762-2766	rate	abstract[149]	giv[149]	_	_
24-7	2767-2770	was	_	_	_	_
24-8	2771-2775	high	_	_	_	_
24-9	2776-2778	as	_	_	_	_
24-10	2779-2783	they	person	giv	_	_
24-11	2784-2788	were	_	_	_	_
24-12	2789-2798	dependent	_	_	_	_
24-13	2799-2801	on	_	_	_	_
24-14	2802-2806	male	person[151]	new[151]	coref	42-20[253_151]
24-15	2807-2813	family	person[151]	new[151]	_	_
24-16	2814-2821	members	person[151]	new[151]	_	_
24-17	2822-2824	to	_	_	_	_
24-18	2825-2830	visit	_	_	_	_
24-19	2831-2834	the	place[152]	giv[152]	coref	29-12[174_152]
24-20	2835-2841	health	place[152]	giv[152]	_	_
24-21	2842-2850	facility	place[152]	giv[152]	_	_
24-22	2851-2852	.	_	_	_	_

#Text=Difficulties in counselling
25-1	2853-2865	Difficulties	abstract[153]	new[153]	_	_
25-2	2866-2868	in	abstract[153]	new[153]	_	_
25-3	2869-2880	counselling	abstract[153]|event	new[153]|new	_	_

#Text=PTBPs with alcohol and other substance abuse also contributed to the attrition .
26-1	2881-2886	PTBPs	event[155]	giv[155]	coref	28-14[0_155]
26-2	2887-2891	with	event[155]	giv[155]	_	_
26-3	2892-2899	alcohol	event[155]|substance	giv[155]|new	_	_
26-4	2900-2903	and	event[155]	giv[155]	_	_
26-5	2904-2909	other	event[155]|abstract[157]	giv[155]|giv[157]	_	_
26-6	2910-2919	substance	event[155]|abstract[157]	giv[155]|giv[157]	_	_
26-7	2920-2925	abuse	event[155]|abstract[157]	giv[155]|giv[157]	_	_
26-8	2926-2930	also	_	_	_	_
26-9	2931-2942	contributed	_	_	_	_
26-10	2943-2945	to	_	_	_	_
26-11	2946-2949	the	event[158]	giv[158]	coref	35-14[0_158]
26-12	2950-2959	attrition	event[158]	giv[158]	_	_
26-13	2960-2961	.	_	_	_	_

#Text=The other important issue was general distrust and unhappiness about the public health system among the public .
27-1	2962-2965	The	abstract[159]	new[159]	coref	27-6[160_159]
27-2	2966-2971	other	abstract[159]	new[159]	_	_
27-3	2972-2981	important	abstract[159]	new[159]	_	_
27-4	2982-2987	issue	abstract[159]	new[159]	_	_
27-5	2988-2991	was	_	_	_	_
27-6	2992-2999	general	abstract[160]	giv[160]	_	_
27-7	3000-3008	distrust	abstract[160]	giv[160]	_	_
27-8	3009-3012	and	_	_	_	_
27-9	3013-3024	unhappiness	_	_	_	_
27-10	3025-3030	about	_	_	_	_
27-11	3031-3034	the	abstract[162]	new[162]	_	_
27-12	3035-3041	public	abstract[162]	new[162]	_	_
27-13	3042-3048	health	abstract|abstract[162]	giv|new[162]	_	_
27-14	3049-3055	system	abstract[162]	new[162]	_	_
27-15	3056-3061	among	abstract[162]	new[162]	_	_
27-16	3062-3065	the	abstract[162]|person[163]	new[162]|new[163]	_	_
27-17	3066-3072	public	abstract[162]|person[163]	new[162]|new[163]	_	_
27-18	3073-3074	.	_	_	_	_

#Text=Thus , these reasons warrant the provision of financial support and assistance to PTBPs to undergo diagnostic tests .
28-1	3075-3079	Thus	_	_	_	_
28-2	3080-3081	,	_	_	_	_
28-3	3082-3087	these	abstract[164]	giv[164]	_	_
28-4	3088-3095	reasons	abstract[164]	giv[164]	_	_
28-5	3096-3103	warrant	_	_	_	_
28-6	3104-3107	the	abstract[165]	new[165]	_	_
28-7	3108-3117	provision	abstract[165]	new[165]	_	_
28-8	3118-3120	of	abstract[165]	new[165]	_	_
28-9	3121-3130	financial	abstract[165]|abstract[166]	new[165]|giv[166]	_	_
28-10	3131-3138	support	abstract[165]|abstract[166]	new[165]|giv[166]	_	_
28-11	3139-3142	and	abstract[165]	new[165]	_	_
28-12	3143-3153	assistance	abstract[165]|abstract[167]	new[165]|new[167]	_	_
28-13	3154-3156	to	abstract[165]|abstract[167]	new[165]|new[167]	_	_
28-14	3157-3162	PTBPs	abstract[165]|abstract[167]|person	new[165]|new[167]|giv	coref	29-9[173_0]
28-15	3163-3165	to	_	_	_	_
28-16	3166-3173	undergo	_	_	_	_
28-17	3174-3184	diagnostic	abstract[169]	new[169]	_	_
28-18	3185-3190	tests	abstract[169]	new[169]	_	_
28-19	3191-3192	.	_	_	_	_

#Text=Third , the rate of TB diagnosis among those PTBPs visiting a health facility was high .
29-1	3193-3198	Third	_	_	_	_
29-2	3199-3200	,	_	_	_	_
29-3	3201-3204	the	abstract[170]	giv[170]	_	_
29-4	3205-3209	rate	abstract[170]	giv[170]	_	_
29-5	3210-3212	of	abstract[170]	giv[170]	_	_
29-6	3213-3215	TB	abstract[170]|event|event[172]	giv[170]|giv|giv[172]	coref|coref	33-13|33-13
29-7	3216-3225	diagnosis	abstract[170]|event[172]	giv[170]|giv[172]	_	_
29-8	3226-3231	among	abstract[170]|event[172]	giv[170]|giv[172]	_	_
29-9	3232-3237	those	abstract[170]|event[172]|person[173]	giv[170]|giv[172]|giv[173]	ana	30-9[177_173]
29-10	3238-3243	PTBPs	abstract[170]|event[172]|person[173]	giv[170]|giv[172]|giv[173]	_	_
29-11	3244-3252	visiting	_	_	_	_
29-12	3253-3254	a	place[174]	giv[174]	ana	30-1[0_174]
29-13	3255-3261	health	place[174]	giv[174]	_	_
29-14	3262-3270	facility	place[174]	giv[174]	_	_
29-15	3271-3274	was	_	_	_	_
29-16	3275-3279	high	_	_	_	_
29-17	3280-3281	.	_	_	_	_

#Text=This could be due to the fact that only those with perceived need reached the health facility .
30-1	3282-3286	This	place	giv	coref	30-15[179_0]
30-2	3287-3292	could	_	_	_	_
30-3	3293-3295	be	_	_	_	_
30-4	3296-3299	due	_	_	_	_
30-5	3300-3302	to	_	_	_	_
30-6	3303-3306	the	abstract[176]	new[176]	_	_
30-7	3307-3311	fact	abstract[176]	new[176]	_	_
30-8	3312-3316	that	abstract[176]	new[176]	_	_
30-9	3317-3321	only	abstract[176]|person[177]	new[176]|giv[177]	coref	31-2[0_177]
30-10	3322-3327	those	abstract[176]|person[177]	new[176]|giv[177]	_	_
30-11	3328-3332	with	abstract[176]|person[177]	new[176]|giv[177]	_	_
30-12	3333-3342	perceived	abstract[176]|person[177]|abstract[178]	new[176]|giv[177]|new[178]	_	_
30-13	3343-3347	need	abstract[176]|person[177]|abstract[178]	new[176]|giv[177]|new[178]	_	_
30-14	3348-3355	reached	abstract[176]	new[176]	_	_
30-15	3356-3359	the	abstract[176]|place[179]	new[176]|giv[179]	_	_
30-16	3360-3366	health	abstract[176]|place[179]	new[176]|giv[179]	_	_
30-17	3367-3375	facility	abstract[176]|place[179]	new[176]|giv[179]	_	_
30-18	3376-3377	.	_	_	_	_

#Text=Though PTBPs were identified by ACF activity , the decision to visit largely depended on the severity of symptoms and thus mimicked the passive case finding .
31-1	3378-3384	Though	_	_	_	_
31-2	3385-3390	PTBPs	event	giv	coref	32-15[191_0]
31-3	3391-3395	were	_	_	_	_
31-4	3396-3406	identified	_	_	_	_
31-5	3407-3409	by	_	_	_	_
31-6	3410-3413	ACF	place|abstract[182]	giv|giv[182]	coref|coref|coref|coref	33-7|36-7[212_182]|33-7|36-7[212_182]
31-7	3414-3422	activity	abstract[182]	giv[182]	_	_
31-8	3423-3424	,	_	_	_	_
31-9	3425-3428	the	abstract[183]	new[183]	_	_
31-10	3429-3437	decision	abstract[183]	new[183]	_	_
31-11	3438-3440	to	_	_	_	_
31-12	3441-3446	visit	_	_	_	_
31-13	3447-3454	largely	_	_	_	_
31-14	3455-3463	depended	_	_	_	_
31-15	3464-3466	on	_	_	_	_
31-16	3467-3470	the	abstract[184]	new[184]	_	_
31-17	3471-3479	severity	abstract[184]	new[184]	_	_
31-18	3480-3482	of	abstract[184]	new[184]	_	_
31-19	3483-3491	symptoms	abstract[184]|abstract	new[184]|giv	coref	32-17[192_0]
31-20	3492-3495	and	_	_	_	_
31-21	3496-3500	thus	_	_	_	_
31-22	3501-3509	mimicked	_	_	_	_
31-23	3510-3513	the	abstract[186]	new[186]	coref	38-6[0_186]
31-24	3514-3521	passive	abstract[186]	new[186]	_	_
31-25	3522-3526	case	abstract[186]	new[186]	_	_
31-26	3527-3534	finding	_	_	_	_
31-27	3535-3536	.	_	_	_	_

#Text=Also , the TAs might have given more preference to referral and linkage of PTBPs with severe and multiple symptoms rather than those with mild symptoms .
32-1	3537-3541	Also	_	_	_	_
32-2	3542-3543	,	_	_	_	_
32-3	3544-3547	the	abstract[187]	giv[187]	_	_
32-4	3548-3551	TAs	abstract[187]	giv[187]	_	_
32-5	3552-3557	might	_	_	_	_
32-6	3558-3562	have	_	_	_	_
32-7	3563-3568	given	_	_	_	_
32-8	3569-3573	more	abstract[188]	new[188]	_	_
32-9	3574-3584	preference	abstract[188]	new[188]	_	_
32-10	3585-3587	to	abstract[188]	new[188]	_	_
32-11	3588-3596	referral	abstract[188]|abstract	new[188]|new	_	_
32-12	3597-3600	and	abstract[188]	new[188]	_	_
32-13	3601-3608	linkage	abstract[188]|abstract[190]	new[188]|new[190]	_	_
32-14	3609-3611	of	abstract[188]|abstract[190]	new[188]|new[190]	_	_
32-15	3612-3617	PTBPs	abstract[188]|abstract[190]|event[191]	new[188]|new[190]|giv[191]	coref	35-17[0_191]
32-16	3618-3622	with	abstract[188]|abstract[190]|event[191]	new[188]|new[190]|giv[191]	_	_
32-17	3623-3629	severe	abstract[188]|abstract[190]|event[191]|abstract[192]	new[188]|new[190]|giv[191]|giv[192]	coref	32-25[193_192]
32-18	3630-3633	and	abstract[188]|abstract[190]|event[191]|abstract[192]	new[188]|new[190]|giv[191]|giv[192]	_	_
32-19	3634-3642	multiple	abstract[188]|abstract[190]|event[191]|abstract[192]	new[188]|new[190]|giv[191]|giv[192]	_	_
32-20	3643-3651	symptoms	abstract[188]|abstract[190]|event[191]|abstract[192]	new[188]|new[190]|giv[191]|giv[192]	_	_
32-21	3652-3658	rather	abstract[188]|abstract[190]|event[191]	new[188]|new[190]|giv[191]	_	_
32-22	3659-3663	than	abstract[188]|abstract[190]|event[191]	new[188]|new[190]|giv[191]	_	_
32-23	3664-3669	those	abstract[188]|abstract[190]|event[191]	new[188]|new[190]|giv[191]	_	_
32-24	3670-3674	with	abstract[188]|abstract[190]|event[191]	new[188]|new[190]|giv[191]	_	_
32-25	3675-3679	mild	abstract[188]|abstract[190]|event[191]|abstract[193]	new[188]|new[190]|giv[191]|giv[193]	coref	36-18[216_193]
32-26	3680-3688	symptoms	abstract[188]|abstract[190]|event[191]|abstract[193]	new[188]|new[190]|giv[191]|giv[193]	_	_
32-27	3689-3690	.	_	_	_	_

#Text=Fourth , the overall yield of ACF was low and NNS for TB was high .
33-1	3691-3697	Fourth	_	_	_	_
33-2	3698-3699	,	_	_	_	_
33-3	3700-3703	the	abstract[194]	new[194]	_	_
33-4	3704-3711	overall	abstract[194]	new[194]	_	_
33-5	3712-3717	yield	abstract[194]	new[194]	_	_
33-6	3718-3720	of	abstract[194]	new[194]	_	_
33-7	3721-3724	ACF	abstract[194]|object	new[194]|giv	coref	41-21
33-8	3725-3728	was	_	_	_	_
33-9	3729-3732	low	_	_	_	_
33-10	3733-3736	and	_	_	_	_
33-11	3737-3740	NNS	abstract	giv	coref	34-5[199_0]
33-12	3741-3744	for	_	_	_	_
33-13	3745-3747	TB	quantity	giv	coref	34-13
33-14	3748-3751	was	_	_	_	_
33-15	3752-3756	high	_	_	_	_
33-16	3757-3758	.	_	_	_	_

#Text=Previous studies have reported lower NNS on mass screening in high burden TB settings .
34-1	3759-3767	Previous	event[198]	giv[198]	coref	44-10[270_198]
34-2	3768-3775	studies	event[198]	giv[198]	_	_
34-3	3776-3780	have	_	_	_	_
34-4	3781-3789	reported	_	_	_	_
34-5	3790-3795	lower	abstract[199]	giv[199]	coref	35-5[206_199]
34-6	3796-3799	NNS	abstract[199]	giv[199]	_	_
34-7	3800-3802	on	abstract[199]	giv[199]	_	_
34-8	3803-3807	mass	abstract[199]|quantity|abstract[201]	giv[199]|new|new[201]	_	_
34-9	3808-3817	screening	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
34-10	3818-3820	in	abstract[199]|abstract[201]	giv[199]|new[201]	_	_
34-11	3821-3825	high	abstract[199]|abstract[201]|abstract[202]|abstract[204]	giv[199]|new[201]|new[202]|new[204]	coref|coref	40-7[235_204]|40-7[235_204]
34-12	3826-3832	burden	abstract[199]|abstract[201]|abstract[202]|abstract[204]	giv[199]|new[201]|new[202]|new[204]	_	_
34-13	3833-3835	TB	abstract[199]|abstract[201]|abstract|abstract[204]	giv[199]|new[201]|giv|new[204]	coref	36-18
34-14	3836-3844	settings	abstract[199]|abstract[201]|abstract[204]	giv[199]|new[201]|new[204]	_	_
34-15	3845-3846	.	_	_	_	_

#Text=A potential reason for high NNS might be the low detection and high attrition rate of PTBPs .
35-1	3847-3848	A	abstract[205]	new[205]	coref	35-9[207_205]
35-2	3849-3858	potential	abstract[205]	new[205]	_	_
35-3	3859-3865	reason	abstract[205]	new[205]	_	_
35-4	3866-3869	for	abstract[205]	new[205]	_	_
35-5	3870-3874	high	abstract[205]|abstract[206]	new[205]|giv[206]	coref	36-2[211_206]
35-6	3875-3878	NNS	abstract[205]|abstract[206]	new[205]|giv[206]	_	_
35-7	3879-3884	might	_	_	_	_
35-8	3885-3887	be	_	_	_	_
35-9	3888-3891	the	abstract[207]	giv[207]	coref	38-4[227_207]
35-10	3892-3895	low	abstract[207]	giv[207]	_	_
35-11	3896-3905	detection	abstract[207]	giv[207]	_	_
35-12	3906-3909	and	abstract[207]	giv[207]	_	_
35-13	3910-3914	high	abstract[207]|quantity[209]	giv[207]|new[209]	_	_
35-14	3915-3924	attrition	abstract[207]|event|quantity[209]	giv[207]|giv|new[209]	_	_
35-15	3925-3929	rate	abstract[207]|quantity[209]	giv[207]|new[209]	_	_
35-16	3930-3932	of	abstract[207]|quantity[209]	giv[207]|new[209]	_	_
35-17	3933-3938	PTBPs	abstract[207]|quantity[209]|abstract	giv[207]|new[209]|giv	_	_
35-18	3939-3940	.	_	_	_	_

#Text=Although the NNS is high , the activity is still worthwhile as it indirectly sensitizes households on TB symptoms and thus creates awareness in the community .
36-1	3941-3949	Although	_	_	_	_
36-2	3950-3953	the	abstract[211]	giv[211]	_	_
36-3	3954-3957	NNS	abstract[211]	giv[211]	_	_
36-4	3958-3960	is	_	_	_	_
36-5	3961-3965	high	_	_	_	_
36-6	3966-3967	,	_	_	_	_
36-7	3968-3971	the	abstract[212]	giv[212]	ana	36-13[0_212]
36-8	3972-3980	activity	abstract[212]	giv[212]	_	_
36-9	3981-3983	is	_	_	_	_
36-10	3984-3989	still	_	_	_	_
36-11	3990-4000	worthwhile	_	_	_	_
36-12	4001-4003	as	_	_	_	_
36-13	4004-4006	it	abstract	giv	_	_
36-14	4007-4017	indirectly	_	_	_	_
36-15	4018-4028	sensitizes	_	_	_	_
36-16	4029-4039	households	place	new	_	_
36-17	4040-4042	on	_	_	_	_
36-18	4043-4045	TB	abstract|abstract[216]	giv|giv[216]	coref|coref	38-14|38-14
36-19	4046-4054	symptoms	abstract[216]	giv[216]	_	_
36-20	4055-4058	and	_	_	_	_
36-21	4059-4063	thus	_	_	_	_
36-22	4064-4071	creates	_	_	_	_
36-23	4072-4081	awareness	abstract	new	_	_
36-24	4082-4084	in	_	_	_	_
36-25	4085-4088	the	abstract[218]	new[218]	coref	37-4[220_218]
36-26	4089-4098	community	abstract[218]	new[218]	_	_
36-27	4099-4100	.	_	_	_	_

#Text=Regular visits to the same community ( six days a week ) is gradually leading to good rapport building with the community .
37-1	4101-4108	Regular	abstract[219]	giv[219]	_	_
37-2	4109-4115	visits	abstract[219]	giv[219]	_	_
37-3	4116-4118	to	abstract[219]	giv[219]	_	_
37-4	4119-4122	the	abstract[219]|abstract[220]	giv[219]|giv[220]	coref	37-21[224_220]
37-5	4123-4127	same	abstract[219]|abstract[220]	giv[219]|giv[220]	_	_
37-6	4128-4137	community	abstract[219]|abstract[220]	giv[219]|giv[220]	_	_
37-7	4138-4139	(	_	_	_	_
37-8	4140-4143	six	time[221]	new[221]	appos	37-10[222_221]
37-9	4144-4148	days	time[221]	new[221]	_	_
37-10	4149-4150	a	time[222]	giv[222]	_	_
37-11	4151-4155	week	time[222]	giv[222]	_	_
37-12	4156-4157	)	_	_	_	_
37-13	4158-4160	is	_	_	_	_
37-14	4161-4170	gradually	_	_	_	_
37-15	4171-4178	leading	_	_	_	_
37-16	4179-4181	to	_	_	_	_
37-17	4182-4186	good	abstract[223]	new[223]	_	_
37-18	4187-4194	rapport	abstract[223]	new[223]	_	_
37-19	4195-4203	building	_	_	_	_
37-20	4204-4208	with	_	_	_	_
37-21	4209-4212	the	abstract[224]	giv[224]	ana	38-1[0_224]
37-22	4213-4222	community	abstract[224]	giv[224]	_	_
37-23	4223-4224	.	_	_	_	_

#Text=This might improve the overall case detection in the community and contribute to TB control efforts .
38-1	4225-4229	This	abstract	giv	coref	38-9[228_0]
38-2	4230-4235	might	_	_	_	_
38-3	4236-4243	improve	_	_	_	_
38-4	4244-4247	the	abstract[227]	giv[227]	_	_
38-5	4248-4255	overall	abstract[227]	giv[227]	_	_
38-6	4256-4260	case	abstract|abstract[227]	giv|giv[227]	_	_
38-7	4261-4270	detection	abstract[227]	giv[227]	_	_
38-8	4271-4273	in	abstract[227]	giv[227]	_	_
38-9	4274-4277	the	abstract[227]|abstract[228]	giv[227]|giv[228]	_	_
38-10	4278-4287	community	abstract[227]|abstract[228]	giv[227]|giv[228]	_	_
38-11	4288-4291	and	_	_	_	_
38-12	4292-4302	contribute	_	_	_	_
38-13	4303-4305	to	_	_	_	_
38-14	4306-4308	TB	abstract|abstract[231]	giv|new[231]	_	_
38-15	4309-4316	control	abstract|abstract[231]	new|new[231]	_	_
38-16	4317-4324	efforts	abstract[231]	new[231]	_	_
38-17	4325-4326	.	_	_	_	_

#Text=The study has several strengths .
39-1	4327-4330	The	abstract[232]	new[232]	ana	40-3[0_232]
39-2	4331-4336	study	abstract[232]	new[232]	_	_
39-3	4337-4340	has	_	_	_	_
39-4	4341-4348	several	abstract[233]	new[233]	_	_
39-5	4349-4358	strengths	abstract[233]	new[233]	_	_
39-6	4359-4360	.	_	_	_	_

#Text=First , it was conducted under programmatic settings and reflects the field realities .
40-1	4361-4366	First	_	_	_	_
40-2	4367-4368	,	_	_	_	_
40-3	4369-4371	it	abstract	giv	coref	42-3[247_0]
40-4	4372-4375	was	_	_	_	_
40-5	4376-4385	conducted	_	_	_	_
40-6	4386-4391	under	_	_	_	_
40-7	4392-4404	programmatic	abstract[235]	giv[235]	_	_
40-8	4405-4413	settings	abstract[235]	giv[235]	_	_
40-9	4414-4417	and	_	_	_	_
40-10	4418-4426	reflects	_	_	_	_
40-11	4427-4430	the	abstract[237]	new[237]	_	_
40-12	4431-4436	field	abstract|abstract[237]	new|new[237]	_	_
40-13	4437-4446	realities	abstract[237]	new[237]	_	_
40-14	4447-4448	.	_	_	_	_

#Text=Second , we used a mixed methods design , which provided considerable insights into challenges involved in the implementation of ACF and enabled us to interpret the quantitative results .
41-1	4449-4455	Second	_	_	_	_
41-2	4456-4457	,	_	_	_	_
41-3	4458-4460	we	person	acc	ana	41-24
41-4	4461-4465	used	_	_	_	_
41-5	4466-4467	a	abstract[240]	new[240]	_	_
41-6	4468-4473	mixed	abstract[240]	new[240]	_	_
41-7	4474-4481	methods	abstract|abstract[240]	new|new[240]	_	_
41-8	4482-4488	design	abstract[240]	new[240]	_	_
41-9	4489-4490	,	_	_	_	_
41-10	4491-4496	which	_	_	_	_
41-11	4497-4505	provided	_	_	_	_
41-12	4506-4518	considerable	abstract[241]	new[241]	_	_
41-13	4519-4527	insights	abstract[241]	new[241]	_	_
41-14	4528-4532	into	abstract[241]	new[241]	_	_
41-15	4533-4543	challenges	abstract[241]|abstract	new[241]|new	_	_
41-16	4544-4552	involved	_	_	_	_
41-17	4553-4555	in	_	_	_	_
41-18	4556-4559	the	abstract[243]	new[243]	_	_
41-19	4560-4574	implementation	abstract[243]	new[243]	_	_
41-20	4575-4577	of	abstract[243]	new[243]	_	_
41-21	4578-4581	ACF	abstract[243]|abstract	new[243]|giv	coref	42-35
41-22	4582-4585	and	_	_	_	_
41-23	4586-4593	enabled	_	_	_	_
41-24	4594-4596	us	person	giv	ana	42-18
41-25	4597-4599	to	_	_	_	_
41-26	4600-4609	interpret	_	_	_	_
41-27	4610-4613	the	abstract[246]	new[246]	_	_
41-28	4614-4626	quantitative	abstract[246]	new[246]	_	_
41-29	4627-4634	results	abstract[246]	new[246]	_	_
41-30	4635-4636	.	_	_	_	_

#Text=Third , the study has a relatively large sample size and there was no selection bias as we included all the individuals who were enumerated during the study reference period in 60 wards where ACF is implemented .
42-1	4637-4642	Third	_	_	_	_
42-2	4643-4644	,	_	_	_	_
42-3	4645-4648	the	abstract[247]	giv[247]	coref	42-28[0_247]
42-4	4649-4654	study	abstract[247]	giv[247]	_	_
42-5	4655-4658	has	_	_	_	_
42-6	4659-4660	a	quantity[249]	new[249]	_	_
42-7	4661-4671	relatively	quantity[249]	new[249]	_	_
42-8	4672-4677	large	quantity[249]	new[249]	_	_
42-9	4678-4684	sample	object|quantity[249]	new|new[249]	_	_
42-10	4685-4689	size	quantity[249]	new[249]	_	_
42-11	4690-4693	and	_	_	_	_
42-12	4694-4699	there	_	_	_	_
42-13	4700-4703	was	_	_	_	_
42-14	4704-4706	no	abstract[251]	new[251]	_	_
42-15	4707-4716	selection	abstract|abstract[251]	new|new[251]	_	_
42-16	4717-4721	bias	abstract[251]	new[251]	_	_
42-17	4722-4724	as	_	_	_	_
42-18	4725-4727	we	person	giv	ana	43-3
42-19	4728-4736	included	_	_	_	_
42-20	4737-4740	all	person[253]	giv[253]	_	_
42-21	4741-4744	the	person[253]	giv[253]	_	_
42-22	4745-4756	individuals	person[253]	giv[253]	_	_
42-23	4757-4760	who	_	_	_	_
42-24	4761-4765	were	_	_	_	_
42-25	4766-4776	enumerated	_	_	_	_
42-26	4777-4783	during	_	_	_	_
42-27	4784-4787	the	time[256]	giv[256]	_	_
42-28	4788-4793	study	abstract|time[256]	giv|giv[256]	coref	44-23[275_0]
42-29	4794-4803	reference	abstract|time[256]	new|giv[256]	_	_
42-30	4804-4810	period	time[256]	giv[256]	_	_
42-31	4811-4813	in	time[256]	giv[256]	_	_
42-32	4814-4816	60	time[256]|place[257]	giv[256]|new[257]	_	_
42-33	4817-4822	wards	time[256]|place[257]	giv[256]|new[257]	_	_
42-34	4823-4828	where	_	_	_	_
42-35	4829-4832	ACF	abstract	giv	_	_
42-36	4833-4835	is	_	_	_	_
42-37	4836-4847	implemented	_	_	_	_
42-38	4848-4849	.	_	_	_	_

#Text=Fourth , we used double data entry and validation using EpiData software and thus data entry errors were minimized .
43-1	4850-4856	Fourth	_	_	_	_
43-2	4857-4858	,	_	_	_	_
43-3	4859-4861	we	person	giv	ana	44-3
43-4	4862-4866	used	_	_	_	_
43-5	4867-4873	double	place[261]	new[261]	coref	43-16[0_261]
43-6	4874-4878	data	abstract|place[261]	new|new[261]	coref	43-15
43-7	4879-4884	entry	place[261]	new[261]	_	_
43-8	4885-4888	and	_	_	_	_
43-9	4889-4899	validation	abstract	new	_	_
43-10	4900-4905	using	_	_	_	_
43-11	4906-4913	EpiData	abstract|object[264]	new|new[264]	_	_
43-12	4914-4922	software	object[264]	new[264]	_	_
43-13	4923-4926	and	_	_	_	_
43-14	4927-4931	thus	abstract[267]	new[267]	_	_
43-15	4932-4936	data	abstract|abstract[267]	giv|new[267]	_	_
43-16	4937-4942	entry	place|abstract[267]	giv|new[267]	_	_
43-17	4943-4949	errors	abstract[267]	new[267]	_	_
43-18	4950-4954	were	_	_	_	_
43-19	4955-4964	minimized	_	_	_	_
43-20	4965-4966	.	_	_	_	_

#Text=Fifth , we adhered to STrengthening the Reporting of Observational studies in Epidemiology ( STROBE ) and COREQ guidelines for reporting the study ’s findings .
44-1	4967-4972	Fifth	_	_	_	_
44-2	4973-4974	,	_	_	_	_
44-3	4975-4977	we	person	giv	_	_
44-4	4978-4985	adhered	_	_	_	_
44-5	4986-4988	to	_	_	_	_
44-6	4989-5002	STrengthening	_	_	_	_
44-7	5003-5006	the	abstract[269]	new[269]	_	_
44-8	5007-5016	Reporting	abstract[269]	new[269]	_	_
44-9	5017-5019	of	abstract[269]	new[269]	_	_
44-10	5020-5033	Observational	abstract[269]|event[270]	new[269]|giv[270]	_	_
44-11	5034-5041	studies	abstract[269]|event[270]	new[269]|giv[270]	_	_
44-12	5042-5044	in	abstract[269]	new[269]	_	_
44-13	5045-5057	Epidemiology	abstract[269]|abstract	new[269]|new	appos	44-15
44-14	5058-5059	(	_	_	_	_
44-15	5060-5066	STROBE	abstract	giv	_	_
44-16	5067-5068	)	_	_	_	_
44-17	5069-5072	and	_	_	_	_
44-18	5073-5078	COREQ	organization|abstract[274]	new|new[274]	_	_
44-19	5079-5089	guidelines	abstract[274]	new[274]	_	_
44-20	5090-5093	for	_	_	_	_
44-21	5094-5103	reporting	_	_	_	_
44-22	5104-5107	the	abstract[276]	new[276]	_	_
44-23	5108-5113	study	abstract[275]|abstract[276]	giv[275]|new[276]	_	_
44-24	5114-5116	’s	abstract[275]|abstract[276]	giv[275]|new[276]	_	_
44-25	5117-5125	findings	abstract[276]	new[276]	_	_
44-26	5126-5127	.	_	_	_	_
